Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study

Paolo Lanzetta, F. Furlan, L. Morgante, D. Veritti, F. Bandello

Research output: Contribution to journalArticle

Abstract

Purpose. To verify the efficacy of nonvisible micropulse diode laser irradiation in the treatment of central serous chorioretinopathy (CSC). Methods. Twenty-two patients with CSC for a total of 24 eyes with a disease duration longer than 3 months were included in a prospective study. Patients underwent Early Treatment Diabetic Retinopathy Study visual acuity (VA) examination, dilated ophthalmoscopy, fluorescein angiograppy, and optical coherence tomography before treatment and during follow-up. Treatment with a micropulse diode laser was given with a duty cycle of 15%. Multiple spots were placed over and adjacent to the area of retinaf pigment epithelium leak or decompensation. Results. Mean follow-up was 14 months (range 3-36 months). Powers used ranged from 1 to 2 W (mean 1.35 W). Mean number of spots was 275 (range 90-400). Fourteen eyes were treated once, nine eyes received two to three treatmonts, and one eye had five treatments during a follow-up of 3 years. Subretinal fluid was resolved or improved in'two third of cases 1 month after laser treatment, and in three-quarters at the end of follow-up. Mean retinal thickness was 328 μm, 197 μm, and 168, μm before, 1 month after irradiation, and at the end of follow-up, respectively. No evidence of RPE or retinal changes due to laser treatment weré discernible in most of the eyes. Median VA was 20/ 32 (range 20/100-20/20) before treatment and 20/25 (range 20/200-20/20) at the end-of the follow-up. Conclusions. Nonvisible micropulse diode laser may have efficacy in the treatment of CSC. A randomized study with larger series is needed.

Original languageEnglish
Pages (from-to)934-940
Number of pages7
JournalEuropean Journal of Ophthalmology
Volume18
Issue number6
Publication statusPublished - 2008

Fingerprint

Central Serous Chorioretinopathy
Semiconductor Lasers
Therapeutics
Visual Acuity
Lasers
Subretinal Fluid
Ophthalmoscopy
Optical Coherence Tomography
Diabetic Retinopathy
Fluorescein
Epithelium
Prospective Studies

Keywords

  • Central serous chorioretinopathy
  • Nonvisible micropulse laser

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. / Lanzetta, Paolo; Furlan, F.; Morgante, L.; Veritti, D.; Bandello, F.

In: European Journal of Ophthalmology, Vol. 18, No. 6, 2008, p. 934-940.

Research output: Contribution to journalArticle

@article{a94510be93954db4a5e45b143aa3866a,
title = "Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study",
abstract = "Purpose. To verify the efficacy of nonvisible micropulse diode laser irradiation in the treatment of central serous chorioretinopathy (CSC). Methods. Twenty-two patients with CSC for a total of 24 eyes with a disease duration longer than 3 months were included in a prospective study. Patients underwent Early Treatment Diabetic Retinopathy Study visual acuity (VA) examination, dilated ophthalmoscopy, fluorescein angiograppy, and optical coherence tomography before treatment and during follow-up. Treatment with a micropulse diode laser was given with a duty cycle of 15{\%}. Multiple spots were placed over and adjacent to the area of retinaf pigment epithelium leak or decompensation. Results. Mean follow-up was 14 months (range 3-36 months). Powers used ranged from 1 to 2 W (mean 1.35 W). Mean number of spots was 275 (range 90-400). Fourteen eyes were treated once, nine eyes received two to three treatmonts, and one eye had five treatments during a follow-up of 3 years. Subretinal fluid was resolved or improved in'two third of cases 1 month after laser treatment, and in three-quarters at the end of follow-up. Mean retinal thickness was 328 μm, 197 μm, and 168, μm before, 1 month after irradiation, and at the end of follow-up, respectively. No evidence of RPE or retinal changes due to laser treatment wer{\'e} discernible in most of the eyes. Median VA was 20/ 32 (range 20/100-20/20) before treatment and 20/25 (range 20/200-20/20) at the end-of the follow-up. Conclusions. Nonvisible micropulse diode laser may have efficacy in the treatment of CSC. A randomized study with larger series is needed.",
keywords = "Central serous chorioretinopathy, Nonvisible micropulse laser",
author = "Paolo Lanzetta and F. Furlan and L. Morgante and D. Veritti and F. Bandello",
year = "2008",
language = "English",
volume = "18",
pages = "934--940",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "6",

}

TY - JOUR

T1 - Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study

AU - Lanzetta, Paolo

AU - Furlan, F.

AU - Morgante, L.

AU - Veritti, D.

AU - Bandello, F.

PY - 2008

Y1 - 2008

N2 - Purpose. To verify the efficacy of nonvisible micropulse diode laser irradiation in the treatment of central serous chorioretinopathy (CSC). Methods. Twenty-two patients with CSC for a total of 24 eyes with a disease duration longer than 3 months were included in a prospective study. Patients underwent Early Treatment Diabetic Retinopathy Study visual acuity (VA) examination, dilated ophthalmoscopy, fluorescein angiograppy, and optical coherence tomography before treatment and during follow-up. Treatment with a micropulse diode laser was given with a duty cycle of 15%. Multiple spots were placed over and adjacent to the area of retinaf pigment epithelium leak or decompensation. Results. Mean follow-up was 14 months (range 3-36 months). Powers used ranged from 1 to 2 W (mean 1.35 W). Mean number of spots was 275 (range 90-400). Fourteen eyes were treated once, nine eyes received two to three treatmonts, and one eye had five treatments during a follow-up of 3 years. Subretinal fluid was resolved or improved in'two third of cases 1 month after laser treatment, and in three-quarters at the end of follow-up. Mean retinal thickness was 328 μm, 197 μm, and 168, μm before, 1 month after irradiation, and at the end of follow-up, respectively. No evidence of RPE or retinal changes due to laser treatment weré discernible in most of the eyes. Median VA was 20/ 32 (range 20/100-20/20) before treatment and 20/25 (range 20/200-20/20) at the end-of the follow-up. Conclusions. Nonvisible micropulse diode laser may have efficacy in the treatment of CSC. A randomized study with larger series is needed.

AB - Purpose. To verify the efficacy of nonvisible micropulse diode laser irradiation in the treatment of central serous chorioretinopathy (CSC). Methods. Twenty-two patients with CSC for a total of 24 eyes with a disease duration longer than 3 months were included in a prospective study. Patients underwent Early Treatment Diabetic Retinopathy Study visual acuity (VA) examination, dilated ophthalmoscopy, fluorescein angiograppy, and optical coherence tomography before treatment and during follow-up. Treatment with a micropulse diode laser was given with a duty cycle of 15%. Multiple spots were placed over and adjacent to the area of retinaf pigment epithelium leak or decompensation. Results. Mean follow-up was 14 months (range 3-36 months). Powers used ranged from 1 to 2 W (mean 1.35 W). Mean number of spots was 275 (range 90-400). Fourteen eyes were treated once, nine eyes received two to three treatmonts, and one eye had five treatments during a follow-up of 3 years. Subretinal fluid was resolved or improved in'two third of cases 1 month after laser treatment, and in three-quarters at the end of follow-up. Mean retinal thickness was 328 μm, 197 μm, and 168, μm before, 1 month after irradiation, and at the end of follow-up, respectively. No evidence of RPE or retinal changes due to laser treatment weré discernible in most of the eyes. Median VA was 20/ 32 (range 20/100-20/20) before treatment and 20/25 (range 20/200-20/20) at the end-of the follow-up. Conclusions. Nonvisible micropulse diode laser may have efficacy in the treatment of CSC. A randomized study with larger series is needed.

KW - Central serous chorioretinopathy

KW - Nonvisible micropulse laser

UR - http://www.scopus.com/inward/record.url?scp=58149388491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149388491&partnerID=8YFLogxK

M3 - Article

C2 - 18988165

AN - SCOPUS:58149388491

VL - 18

SP - 934

EP - 940

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 6

ER -